{"disease":{"id":"curative-treatment","name":"curative treatment"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04290936","title":"Tenofovir Alafenamide(TAF) Reduces the Risk of Hepatocellular Carcinoma(HCC) Recurrence","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":402,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT05774964","title":"Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Liaoning Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT02824185","title":"Combined Fluorocholine Positron Emission Tomography and Magnetic Resonance Imaging (FCH-PET/MRI) in Curative Treatment of a Hepatocellular Carcinoma","phase":"NA","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT02030847","title":"Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"University of Pennsylvania","has_results":true},{"nct_id":"NCT06230549","title":"Adaptive Radiotherapy in Patients With Gynecological Tumors","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"University Hospital, Essen","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}